Resource library
Below you will find a range of useful resources on the key themes and content presented at the Think Again Lung Summit 2024
This is a promotional website intended for UK healthcare professionals only. Non healthcare professionals please visit astrazeneca.co.uk.
This is a promotional website intended for UK healthcare professionals only. Non healthcare professionals
please visit astrazeneca.co.uk.
The Think Again Lung Summit 2024 was a promotional meeting funded and organised by AstraZeneca and contained both educational and promotional material.
AstraZeneca products were discussed in this meeting. Prescribing Information and adverse events reporting details are available below.
Highlights video of the day
View the presentations from Lung Summit 2024
All presentations are designed to be viewed online only
Lung cancer screening
in practice
in practice
Overview of current lung cancer screening programs, with a particular focus on the impact of screening on the MDT.
Implementing and optimising locally advanced MDTs
The rationale behind introducing a locally advanced MDT in the Newcastle upon Tyne Hospitals NHS, including practical steps on how to implement one.
Managing crucial patient conversations
An overview of genomic testing in lung cancer, including case studies on how to manage conversations with patients around test results and treatment plans moving forward.
Optimising
the patient journey
the patient journey
How to leverage prehabilitation and how to manage adverse events appropriately to improve patient outcomes.
Navigating the treatment landscape: CODAK
Summary of current curative intent rates, with a focus on real-world data from the PACIFIC regimen (CODAK).
An MDT perspective:
Patient case studies discussion
Patient case studies discussion
Three complex, multi-modality patient case studies whose treatment plans were debated by our MDT.
The authors/owners of these presentations have given permissions for the slides to be viewed here for educational purposes only. Should you wish to utilise the slides for any other purposes, permission must be acquired from the author/owner.
For questions related to the Think Again Lung Summit, please contact us:
IMFINZI®▼(durvalumab) prescribing information for Great Britain can be found here
IMFINZI® (durvalumab) prescribing information for Northern Ireland can be found here
TAGRISSO® (osimertinib) prescribing information for Great Britain can be found here
TAGRISSO® (osimertinib) prescribing information for Northern Ireland can be found here
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.
GB-56010 | July 2024
© AstraZeneca 2024. All rights reserved.
AstraZeneca Lung Summit 2024 - Resources Page
The content on this website is intended for UK Healthcare professionals only. The website contains promotional content.